8月25日消息，继与京东商城共同增资上海云健康后，上海医药的市值被市场看好。此前，交银国际对外宣布将维持上海医药的买入评级，目标价24.04港币。亿邦动力网发现，从今天上海医药的开盘价17.08元来看，该价格较昨日的收盘价低5个百分点，但截止到发稿，上海医药的价格已上扬至17.58元，有望突破昨日最高价17.69元。目前，上海医药的总市值已达到467亿元。图为上海医药最新股价变动图今日，上海医药对外发声称，与京东商城开展合作后，公司将在处方药的在线销售市场中领先于竞争对手，这主要依赖于京东商城的线上流通体系和线下物流实力。据了解，上海医药在今年的5月份就与京东商城达成了战略合作，双方将共同搭建...
8 June 25, following the Jingdong Mall and joint capital Shanghai Health cloud after, Shanghai pharmaceutical market is optimistic about the market. Previously, the silver international announced that it will maintain the purchase of medicine in Shanghai, the target price of 24.04 Hong Kong dollars. Billion state power network found that from today Shanghai Pharma's opening price of $17.08 point of view, the price is yesterday's closing price of 5 percentage points, but as of press time, the prices of Shanghai Pharmaceutical has surged to 17.58 yuan, is expected to exceed the highest price of 17.69 yuan yesterday. At present, the total market value of Shanghai pharmaceutical has reached 46700000000 yuan. The picture for the latest share price changes in Shanghai medical chart today, Shanghai Pharmaceutical Foreign voice said, and Jingdong Mall after cooperation, the company will be in the online sales of prescription drugs in the market ahead of competitors, which mainly depends on Jingdong Mall online distribution system and line logistics strength. It is understood that the Shanghai pharmaceutical in May this year, Jingdong Mall reached a strategic cooperation, the two sides will jointly build...
